Literature DB >> 6489771

Healon in retinal detachment with proliferative vitreoretinopathy.

E Gerke, G Meyer-Schwickerath, A Wessing.   

Abstract

In 73 eyes, retinal detachments complicated by proliferative vitreoretinopathy (PVR) were treated by intravitreal injections of Healon, in addition to scleral buckling procedures. The number of completely reattached retinas three months postoperatively was dependent upon the grade of PVR: 50% were reattached when PVR comprised only one quadrant (Grade C-1); 30% when two to four quadrants were involved (Grade C-2, C-3 and D-1). Reattachment was not achieved in two cases of PVR with funnel-like configurations (D-2). Major complications that could be attributed to Healon did not occur. The results indicate that Healon injections, combined with scleral buckling procedures, are an encouraging approach to retinal detachments with PVR Grades C-2 through D-1.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6489771     DOI: 10.1007/bf02134147

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  8 in total

1.  The treatment of massive vitreous retraction by the separation of pre-retinal membranes using liquid silicone.

Authors:  J D Scott
Journal:  Mod Probl Ophthalmol       Date:  1975

2.  Massive periretinal proliferation: a logical approach to therapy.

Authors:  R Machemer
Journal:  Trans Am Ophthalmol Soc       Date:  1977

3.  Temporary use of intraocular silicone oil in the treatment of detachment with massive periretinal proliferation. Preliminary report.

Authors:  M Gonvers
Journal:  Ophthalmologica       Date:  1982       Impact factor: 3.250

4.  Hyaluronic acid and replacement of vitreous and aqueous humor.

Authors:  E A Balazs; M I Freeman; R Klöti; G Meyer-Schwickerath; F Regnault; D B Sweeney
Journal:  Mod Probl Ophthalmol       Date:  1972

5.  Scleral buckling for retinal detachments complicated by periretinal proliferation.

Authors:  W S Grizzard; G F Hilton
Journal:  Arch Ophthalmol       Date:  1982-03

6.  The classification of retinal detachment with proliferative vitreoretinopathy.

Authors: 
Journal:  Ophthalmology       Date:  1983-02       Impact factor: 12.079

7.  Silicone oil in the treatment of massive preretinal retraction. I. Results in 105 eyes.

Authors:  R H Grey; P K Leaver
Journal:  Br J Ophthalmol       Date:  1979-05       Impact factor: 4.638

8.  Hyaluronic acid vitreous substitute. A six-year clinical evaluation.

Authors:  R C Pruett; C L Schepens; D A Swann
Journal:  Arch Ophthalmol       Date:  1979-12
  8 in total
  8 in total

1.  Inflow and outflow relations after intraocular fluid-Healon exchange in a case of chronic ocular hypotension.

Authors:  F Koerner; P Niesel; H König
Journal:  Int Ophthalmol       Date:  1985-11       Impact factor: 2.031

2.  Experimental vitreous tamponade using polyalkylimide hydrogel.

Authors:  Sven Crafoord; Sten Andreasson; Fredrik Ghosh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-03-31       Impact factor: 3.117

3.  Evaluation of viscoelastic poly(ethylene glycol) sols as vitreous substitutes in an experimental vitrectomy model in rabbits.

Authors:  Christopher D Pritchard; Sven Crafoord; Sten Andréasson; Karin M Arnér; Timothy M O'Shea; Robert Langer; Fredrik K Ghosh
Journal:  Acta Biomater       Date:  2010-11-24       Impact factor: 8.947

4.  A cross-linked hyaluronic acid hydrogel (Healaflow(®)) as a novel vitreous substitute.

Authors:  Henrik Barth; Sven Crafoord; Sten Andréasson; Fredrik Ghosh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-01-08       Impact factor: 3.117

5.  A new model for in vitro testing of vitreous substitute candidates.

Authors:  Henrik Barth; Sven Crafoord; Timothy M O'Shea; Christopher D Pritchard; Robert Langer; Fredrik Ghosh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-07-25       Impact factor: 3.117

Review 6.  Hyaluronic acid. A review of its pharmacology and use as a surgical aid in ophthalmology, and its therapeutic potential in joint disease and wound healing.

Authors:  K L Goa; P Benfield
Journal:  Drugs       Date:  1994-03       Impact factor: 9.546

7.  Age-Related Loss of Human Vitreal Viscoelasticity.

Authors:  André Schulz; Silke Wahl; Annekatrin Rickmann; Jannine Ludwig; Boris V Stanzel; Hagen von Briesen; Peter Szurman
Journal:  Transl Vis Sci Technol       Date:  2019-06-28       Impact factor: 3.283

8.  Increasing Silicone Oil Viscosity Increases Resistance to Volume Displacement in an in vitro Retinal Detachment Model.

Authors:  Alexander Rubowitz; Leena Asalee; Uri Zaretski
Journal:  Biomed Hub       Date:  2018-11-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.